The genes related to minocycline were then obtained by network pharmacology analysis and intersected with COVID-19, RA, and pyroptosis to obtain the common hub gene, and then the key gene was verified as CASP1 by two validation sets. Here, CASP1 is linked to rheumatoid arthritis.